Agresta Samuel
- SEC CIK
- 0001748961
No open-market purchases or sales filed in the past year.
Current role at each company
- OKUR OnKure Therapeutics, Inc.Chief Medical Officeras of Aug 11, 2026
- FHTX Foghorn Therapeutics Inc.Chief Medical Officeras of Sep 13, 2023
- INFI Infinity Pharmaceuticals, Inc.Directoras of Jun 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Agresta Samuel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FHTX Foghorn Therapeutics Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2023 (view filing) | Aug 16 | 2 days | Agresta SamuelChief Medical Officer | SSale | −311.3K | $8.25 | −$2.57M | −100.0%0 after |